Harpoon Therapeutics (NASDAQ:HARP), a biotechnology company developing an antibody platform to treat different forms of cancer, climbed approximately 20% in the last 10 minutes of trading on Friday, May 29, to close at $21.76 per share. Earlier in the day, […]